度他雄胺治疗前额纤维化性秃发的系统评价与Meta分析
该系统评价与Meta分析纳入7项研究共366例口服度他雄胺的前额纤维化性秃发患者,采用随机效应模型合并分析。结果显示病情稳定估计比例为0.628(95%CI:0.398-0.859),改善亚组估计比例为0.356(95%CI:0.163-0.549)。提示口服度他雄胺是FFA病情稳定或改善的良好治疗选择。
要点
- FFA尚缺乏确切证实的治疗,度他雄胺可作为潜在治疗选择。
核心结论
- 口服度他雄胺对前额纤维化性秃发患者的病情稳定或改善是良好的治疗选择。
研究设计与样本
- 系统评价与Meta分析,遵循PRISMA 2020标准,纳入7项研究共366例口服度他雄胺的FFA患者,采用ROBINS-I评估偏倚风险,随机效应模型合并分析。
主要发现
- 口服度他雄胺治疗FFA的病情稳定估计比例为0.628(95%CI:0.398-0.859)。
- 在病情稳定患者中,改善的估计比例为0.356(95%CI:0.163-0.549)。
关键数值与推荐
- 病情稳定估计比例0.628(95%CI:0.398-0.859),改善估计比例0.356(95%CI:0.163-0.549)。
临床怎么用
- 对于前额纤维化性秃发患者,可考虑口服度他雄胺以促进病情稳定或改善。
局限性
- 纳入研究为非随机干预研究,采用ROBINS-I评估偏倚风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Frontal fibrosing alopecia (FFA) is a scarring alopecia with fronto-temporo-parietal hairline recession. Although no proven treatment for FFA exists, dutasteride has been suggested as a potential treatment option. We aimed to evaluate the therapeutic response of oral dutasteride in FFA patients. The identification and selection of studies were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis 2020 criteria. To assess the risk of bias for each study, we used the Cochrane's risk of bias in non-randomized studies of interventions (ROBINS-I) assessment tool. A random effects model meta-analysis was performed. Estimated proportion of stabilization for eligible studies was calculated to evaluate the effectiveness of dutasteride for treating FFA. Among patients who achieved stabilization, subgroup analysis was conducted on those showing improvement. Seven studies including 366 patients who received oral dutasteride were identified. The estimated proportion of patients who experienced stabilization of FFA with oral dutasteride was 0.628 (95% CI: 0.398-0.859). In subgroup analyses of patients who experienced improvement, the estimated proportion of improvement was 0.356 (95% CI: 0.163-0.549). In this systematic review and meta-analysis, oral dutasteride revealed to be a good treatment option for disease stabilization or improvement in patients with FFA.
引用
- Seo HM, Oh SU, Kim S, et al. Dutasteride in the treatment of frontal fibrosing alopecia: Systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2024. PMID: 38357767. doi:10.1111/jdv.19802
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。